InvestorsHub Logo
icon url

wrinklesobw

07/25/22 1:28 PM

#148601 RE: Roofus #148600

It’ll happen, when who knows.

They get ide approval this will move pretty high then come back down and settle in probably around a $1.00 maybe a bit higher.

Also as they get more clinics set up for isopet more revenue will come in, but that will take some time to build a constant revenue stream


Who knows a buyout could happen anytime after ide approval.

$5 within the next year is very doable.
icon url

splintered sunlight

07/25/22 1:28 PM

#148602 RE: Roofus #148600

How about a dime?
icon url

SC8

07/25/22 1:44 PM

#148604 RE: Roofus #148600

Assuming IDE approved, $5 certainly possible at some point but who knows when? Maybe in a volume fomo pop upon IDE approval before next offering? But I'm thinking would need positive human trial data to sustain price near $5. At that point RDGL would be a buyout play. Too far down road for me to worry about. I'm still looking to exit upon IDE approval and not looking beyond that. Might consider buying back in after the dust settles post IDE.